Zoryve Foam 0.3% topical foam Images
Generic Name: roflumilast
This medication has been identified as Zoryve Foam 0.3% topical foam. It is supplied by Arcutis Biotherapeutics, Inc.
Zoryve Foam is used in the treatment of Seborrheic Dermatitis and belongs to the drug class selective phosphodiesterase-4 inhibitors. Zoryve Foam 0.3% topical foam is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zoryve Foam
- Generic Name
- roflumilast
- Strength
- 0.3% topical foam
- Availability
- Prescription only
- Drug Class
- Selective phosphodiesterase-4 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Arcutis Biotherapeutics, Inc.
- National Drug Code (NDC)
- 80610-0430
More about Zoryve Foam (roflumilast topical)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
